NLM Logo

Axitinib MeSH Descriptor Data 2022


MeSH Heading
Axitinib
Tree Number(s)
D02.065.277.051
D02.241.223.100.100.115
D02.455.426.559.389.127.085.093
D03.383.129.539.487.065
D03.633.100.449.065
Unique ID
D000077784
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077784
Scope Note
A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA.
Entry Term(s)
AG 013736
AG-013736
AG013736
Inlyta
Pharm Action
Antineoplastic Agents
Protein Kinase Inhibitors
Registry Number
C9LVQ0YUXG
CAS Type 1 Name
Benzamide, N-methyl-2-((3-((E)-2-(2-pyridinyl)ethenyl)-1H-indazol-6-yl)thio)-
Public MeSH Note
2019; AXITINIB was indexed under IMIDAZOLES and INDAZOLES 2005-2018
History Note
2019 (2005)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/05/21
Axitinib Preferred
AG 013736 Narrower
Inlyta Narrower
page delivered in 0.151s